Lee Financial’s Core Laboratories CLB Stock Holding History

Lee Financial’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-23	Closed	-$3K	–	511
2018 Q2	$3K	Hold	23	–	–	﹤0.01%	680
2018 Q1	$2K	Buy	+23	New	+$2.54K	﹤0.01%	698

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Royal London Asset Management United Kingdom $54.3B AUM 39.21% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lee Financial's CLB Position: Q3 2018 in Review

Lee Financial sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 23 shares — an estimated $3K sold.

Lee Financial first reported a position in CLB in Q1 2018 and held it in 2 quarters. The position peaked at $3K in Q2 2018. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

Lee Financial reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
Lee Financial sold 23 Core Laboratories shares in Q3 2018, an estimated $3K.
Lee Financial first reported a position in Core Laboratories in Q1 2018 and held it in 2 quarters.
Lee Financial's Core Laboratories position peaked at $3K in Q2 2018.
359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Lee Financial's 13F filing for Q3 2018, filed 7 Nov 2018.